COMPANY OVERVIEW

None

---

LOCATION

---

THERAPEUTIC AREAS

---

WEBSITE

None

---

CAREER WEBSITE

None

---

SOCIAL MEDIA

---

INVESTORS

---

PRESS RELEASES

May 19, 2022

Vedere Bio II Presents Positive New Data Supporting Its Proprietary Platform at the 25th Annual ASGCT Meeting

May 2, 2022

Vedere Bio II to Present Two Abstracts at the ASGCT 2022 Annual Meeting

Apr 26, 2022

Vedere Bio II Appoints Accomplished Clinician and Researcher Anna-Maria Demetriades as Chief Medical Officer

Apr 12, 2022

Vedere Bio II Announces Appointment of Industry Veteran Gina Consylman as Chief Financial Officer

Feb 8, 2022

Vedere Bio II Appoints Martina Schinke, Ph.D., as Vice President, Program Leader

For More Press Releases

---